The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced a new regulatory framework that requires bioequivalence (BE) tests for all generic medications, a bold step to improve the quality, safety, and effectiveness of pharmaceutical products in Nigeria. Prof. Mojisola Christianah Adeyeye, NAFDAC Director General, announced that the new requirement ensures that [...]
Related Articles
Don't miss out on breaking stories and in-depth articles.